Product Name | Topiramate |
Synonyms | 2,3:4,5-Bis-O-(1-methylethylidene)--D-fuctopyranoseSulfamate,McN-4853,RWJ-17021-000,Topamax;McN4853,RWJ17021,Topamax,2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranosesulfamate;Topimax;TopiramicacidChemicalbook;1-O-Sulfamoyl-2-O,3-O:4-O,5-O-bis(1-methylethylidene)-β-D-fructopyranose;1-O-Sulfamoyl-2-O,3-O:4-O,5-O-diisopropylidene-β-D-fructopyranose;Topina;2,3:4,5-Di-O-isopropylidene-β-D-fructopyranosidesulfamate |
MOQ | 1kg |
CAS | 97240-79-4 |
Appearance | white |
Molecular Formula | C12H21NO8S |
Molecular Weight | 339.36 |
Assay | >99% |
Application | For research purpose only |
Packing | 25kg/drum |
Storage | Store in a well-closed,light-resistant container |
Remarks | NA |
Custom synthesis | Available |
Topiramate (the TPM) is a naturally existing monosaccharide D-fructose sulfide, and together with felbamate, lamotrigine and vigabatrin are current several broad-spectrum anti-epileptic drugs with relatively wide clinical application and can be used to control different types of epilepsy with excellent efficacy and pharmacokinetics.
This product is generally used for the adjuvant treatment of antiepileptic drugs and is effective in treating simple and complex seizures as well as systemic tonic-clonic seizures and can also be used for the treatment of infantile spasms. Features of this product include excellent long-term efficacy, no significant resistance as well as being able to be used alone for antiepileptic purpose.
Certification